Humana (HUM, Managed Health Care) Stock Valuation & Fair Value Significantly overvalued
Humana (HUM, Managed Health Care) trades at a blended P/E of 30.4 — about 80% above its historical normal valuation — with a forward growth estimate of 30.9% and a PEG of 0.98. Analysts' one-year estimates have been hit 73% of the time.
Valuation flags
- Overvalued by 80%
Verdict history
tickerseer's rating has been significantly overvalued since 2026-06-10.
Frequently asked questions
Is Humana stock overvalued?
At a blended P/E of 30.4 versus its historical normal P/E of 16.9, Humana trades about 80% above its typical valuation, with a PEG of 0.98 on 30.9% forward growth — tickerseer currently rates it significantly overvalued.
What is Humana's fair value and PEG?
Humana trades at a blended P/E of 30.4 against a historical normal P/E of 16.9, a PEG of 0.98, and a forward growth estimate of 30.9%.
Has tickerseer's rating of Humana changed?
tickerseer's rating has been significantly overvalued since 2026-06-10.
Industry: Managed Health Care. Create a free account to unlock the full analysis — the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.